The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shishkova V.N.

National Medical Research Center for Therapy and Preventive Medicine Federal State Budgetary Institution the Ministry of Health of Russia;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry Federal State Budgetary Educational Institution of Higher Education

Adasheva T.V.

Evdokimov Moscow State University of Medicine and Dentistry

Cerebrovascular disease in patients with type 2 diabetes mellitus

Authors:

Shishkova V.N., Adasheva T.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6): 114‑118

DOI: 10.17116/jnevro2021121061114

Read: 2420 times

Download PDF (RU)
Contact the author
Table of contents

CEREBROVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
CEREBROVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

To cite this article:

Shishkova VN, Adasheva TV. Cerebrovascular disease in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6):114‑118. (In Russ.)
https://doi.org/10.17116/jnevro2021121061114

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Functional state of the kidneys in patients with various types of cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):105-111
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
The role of quantitative body composition analysis in popu­lation in the asse­ssment and moni­toring of cardiovascular risk meta­bolic factors. Russian Journal of Preventive Medi­cine. 2024;(12):128-134
Restoration of spermatogenesis suppressed by the use of testosterone, antiestrogen therapy in men with type 2 diabetes mellitus. Russian Journal of Human Reproduction. 2024;(6):156-160
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Inci­dence of diseases of the circulatory system in the working-age popu­lation of the Ural Fede­ral District in 2012—2022. Russian Journal of Preventive Medi­cine. 2025;(1):24-29
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Abstract:

The article discusses the current trends in the spread of carbohydrate disorders, discusses in more detail the problem of type 2 diabetes mellitus and associated cerebrovascular diseases. The spectrum of the therapeutic effect of the drugs neurox and neupilept is considered in relation to this category of patients.

Keywords:

diabetes mellitus
cerebrovascular diseases
neurox
neupilept

Authors:

Shishkova V.N.

National Medical Research Center for Therapy and Preventive Medicine Federal State Budgetary Institution the Ministry of Health of Russia;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry Federal State Budgetary Educational Institution of Higher Education

Adasheva T.V.

Evdokimov Moscow State University of Medicine and Dentistry

Received:

13.05.2021

Accepted:

01.06.2021

Close metadata

References:

  1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract. 2019;157:107843. Epub 2019 Sep 10.  https://doi.org/10.1016/j.diabres.2019.107843
  2. Shestakova MV, Vikulova OK, Zheleznyakova AV, et al. Diabetes epidemiology in russia: what has changed over the decade? Terapevticheskii Arkhiv. 2019;91(10):4-13. (In Russ.). https://doi.org/10.26442/00403660.2019.10.000364
  3. Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016;19(2):104-112. (In Russ.). https://doi.org/10.14341/DM2004116-17
  4. Shishkova VN. The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management. Systemic Hypertension. 2014;2:48-53. (In Russ.).
  5. Shishkova VN. mechanisms of cardiovascular diseases development in obesity and insulin resistance: focus on atherothrombosis. Russian Journal of Cardiology. 2016;21(9):72-78. (In Russ.). https://doi.org/10.15829/1560-4071-2016-9-72-78
  6. Dedov II, Shestakova MV, Vikulova OK et al. Atlas of diabetes register in russian federation, status 2018. Diabetes Mellitus. 2019;22(2-2):4-61. (In Russ.).
  7. Shamalov NA, Stakhovskaya LV, Klochihina OA, Polunina OS, Polunina EA. The analysis of the dynamics of the main types of stroke and pathogenetic variants of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(3 vyp 2):5-10. (In Russ.). https://doi.org//10.17116/jnevro20191190325
  8. Skvortsova VI, Shetova IM, Kakorina EP, et al. Results of implementation of a «complex of measures to improve medical care for patients with stroke in the russian federation». Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(4):5-12. (In Russ.). https://doi.org/10.17116/jnevro2018118415-12
  9. Tanashyan MM, Antonova KV, Lagoda OV, et al. Acute cerebral circulatory disorders and type 2 diabetes mellitus. Annals of Clinical and Experimental Neurology/Annaly Klinicheskoy i Eksperimental’noy Nevrologii. 2014;8(3):4-8. (In Russ.).
  10. Tanashyan MM. Vascular diseases of the brain and metabolic syndrome. M.: AST 345; 2017. (In Russ.).
  11. Shishkova VN, Adasheva TV, Remenik AYu, et al. Prognostic significance of clinical-anthropometric, biochemical, metabolic, vascular-inflammatory and molecular-genetic markers in the development of the first ischemic. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(2):4-11. (In Russ.). https://doi.org/10.17116/jnevro2018118214-11
  12. Shishkova VN, Adasheva TV, Stakhovskaya LV. the role of diabetes mellitus and a gender factor in the development of a second noncardioembolic ischemic stroke. Vrach (The Doctor). 2020;10:50-54. (In Russ.). https://doi.org/10.29296/25877305-2020-10-09
  13. Ostroumova OD, Surkova EV, Chikh EV. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes Mellitus. 2018;21(4):307-18. (In Russ.). https://doi.org/10.14341/DM9660
  14. Levin OS Cognitive impairment in diabetes and metabolic syndrome. Current Therapy of Mental Disorders/Sovrem. Ter. Psih. Rasstrojstv. 2015;4:18-25. (In Russ.).
  15. Shishkova VN, Kapustina LA. Features of the development of cognitive impairment in patients with type 2 diabetes mellitus and metabolic syndrome. Vrach (The Doctor). 2018;9:3-10. (In Russ.). https://doi.org/10.29296/25877305-2018-09-01
  16. Shishkova VN. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: possibility for correction and prevention. Terapevticheskii Arkhiv. 2015;87(1):109-114. (In Russ.). https://doi.org/10.17116/terarkh2015871109-114
  17. Parfenov VA. Dyscirculatory encephalopathy and vascular cognitive disorders. M.: IMA-PRESS; 2017. (In Russ.).
  18. Pulina MV, Teplova MV. Rational pharmacotherapy of chronic cerebral ischemia. Clinical recommendations. M.: MEDpressinform; 2019. (In Russ.).
  19. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269. https://doi.org/10.1002/14651858.CD000269.pub2
  20. Singh M, Khan MI, Giri R, Kumar L. Rol of citicoline in improvement of cognition, memory and post stroke disability in stroke patients. Int J Advances Med. 2019;6(2):429.  https://doi.org/10.18203/2349-3933.ijam20191154
  21. Bogolepova AN. the role of oxidative stress in the development of vascular cognitive disorders. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(8):133-139. (In Russ.). https://doi.org/10.17116/jnevro2020120081133
  22. Badalyan OL, Savenkov AA, Taisheva KH, et al. The possibilities of using neurox in the complex treatment of chronic brain ischemia. RMJ (Russian Medical Journal). 2010;18(8):455-459. (In Russ.).
  23. Solovyeva EYu, Karneev AN, Chekanov AV, et al. The individual and combined antioxidant effects of citicoline and ethylmethylhydroxypyridini succinas. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2016;116(11):78-85. (In Russ.). https://doi.org/10.17116/jnevro201611611178-85
  24. Solovyeva EYu, Karneev AN, Chekanov AV, et al. The study of membrane-protective and and antioxidant potentials of citicoline and ethylmethylhydroxypyridine with combined usage. Pacific Medical Journal. 2019;1:74-80. (In Russ.).
  25. Solovyeva EYu, Karneev AN, Chekanov AV, et al. The study of the membrane-protective potential of the combination of 2-ethyl-6-methyl-3-hydroxypyridine-succinate and citicoline. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(1):18-22. (In Russ.). https://doi.org/10.17116/jnevro20181181118-22
  26. Soloveva EYu, Amelina IP. cerebral small vessel disease’s impact on the development of chronic cerebral ischemia: paradigms of treatment. Medical Council/Meditsinskiy Sovet. 2020;2:16-24. (In Russ.). https://doi.org/10.21518/2079-701X-2020-2-16-24
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.